Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

The long-term effects of treatment with sirolimus-eluting stents, as compared with bare-metal stents, have not been established.

We performed an analysis of individual data on 4958 patients enrolled in 14 randomized trials comparing sirolimus-eluting stents with bare-metal stents (mean follow-up interval, 12.1 to 58.9 months). The primary end point was death from any cause. Other outcomes were stent thrombosis, the composite end point of death or myocardial infarction, and the composite of death, myocardial infarction, or reintervention.